California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday.
Breaking News
Subscribe to VCpost newsletter
Most Popular
- 940,000 Taxpayers May Receive Extra $932 Tax Refunds From IRS; Here's Why!
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- Proposed Chinese Train Station Garners Attention Online as It Looks Like Sanitary Pad
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Verizon $100 Million Settlement: How to Get Free 1-Month Home Internet Today?
